<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-ketorolac.xml</id>
  <title>Recalls Watch: Ketorolac</title>
  <link rel="self" href="https://recalls.watch/feed/substance-ketorolac.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2025-12-17T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/98040/</id>
    <title>Fagron Compounding Services: Tropicamide 1%/Cyclopentolate 1%/Phenylephrine 2.5%/Ketorolac 0.5% Topical Ophthalmic…</title>
    <link href="https://recalls.watch/recall/fda/98040/"/>
    <updated>2025-12-17T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Incorrect Product Formulation</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97711/</id>
    <title>Aspiro Pharma Limited: Ketorolac Tromethamine Injection</title>
    <link href="https://recalls.watch/recall/fda/97711/"/>
    <updated>2025-10-29T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of Particulate Matter: Particulate matter identified as glass</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97561/</id>
    <title>Apotex Corp.: Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution and 1 more</title>
    <link href="https://recalls.watch/recall/fda/97561/"/>
    <updated>2025-10-08T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96954/</id>
    <title>Apotex Corp.: Ketorolac Tromethamine Ophthalmic Solution and 2 more</title>
    <link href="https://recalls.watch/recall/fda/96954/"/>
    <updated>2025-07-02T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/93453/</id>
    <title>Fagron Compounding Services: Tropicamide 1%</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=93453"/>
    <updated>2023-12-06T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Labeling: Label Mix-Up: The label of a dropper bottle mistakenly states the container is a 0.5mL single-use syringe instead of a 5 mL dropper</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/91788/</id>
    <title>Akorn, Inc.: Atropine Sulfate Ophthalmic Solution and 85 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=91788"/>
    <updated>2023-06-07T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations: Firm went out of business and could no longer continue stability studies.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/90948/</id>
    <title>Akorn, Inc.: AK-POLY-BAC brand of Bacitracin cand Polymixin B Sulfate Ophthalmic Ointment USP and 26 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=90948"/>
    <updated>2023-01-25T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations:</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/71681/</id>
    <title>Hospira Inc.: KETOROLAC Tromethamine Inj. and 1 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=71681"/>
    <updated>2015-07-22T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Crystallization; identified as calcium salt of Ketorolac</summary>
  </entry>
</feed>
